great dialog on here, I was searching for active chatter on...

great dialog on here, I was searching for active chatter on Elixinol and finally found it. I'm in U.S., have been doing some due diligence on Elixinol, running through some napkin math of valuation based on potential earnings, etc, I've posted it on reddit, if anyone interested:

https://www.reddit.com/r/weedstocks/comments/9hpwee/elixinol_the_sleeping_giant_of_the_hemp_market/

anyone have thoughts on upcoming Q3 performance, the Medical MJ division is obviously the one dragging until it gets Australia licenses right? The U.S. division which is running the hemp/cbd operations from Colorado did $2.2M net income in 1H 2018, when offset with other divisions, the net income for whole company in 1H 2018 was .8M. CBD is in big demand in U.S. in variety of forms, seems realistic that U.S. division shows growth in 2H 2018, tough to gauge how much, no visibility on how much of the extra grow capacity from the NCHPP(North CO High Plains Producers) 700 acres is in production yet?

If they can post somewhere between 4M to 8M in net income for whole company in 2H 2018, which shouldn't be that crazy given they have made building out their sales/distribution channels a priority with the latest funding raise, those numbers make them more profitable of course, but also potentially cheaper or at least competitive on a per share earnings multiple/basis than the defacto leader, CWEB(Charlottes Web), and still on the growth side.